Scarlet empowers companies building the next generation of medical software – the software that’ll bring accessible and affordable healthcare to everyone on the planet.

The current regulatory environment wasn’t designed for software, yet it’s software – and especially AI – building the future of health and medicine.

Scarlet creates a new framework for software companies and regulators alike: providing them with a way to build and surveil products in a continuous and scalable way.

This means better and safer products can be deployed efficiently. It means we’re one step closer to universally equitable healthcare.

Scarlet was founded in late 2020 by James Dewar and James Cox, our investors include EF and Kindred Capital.

Open Positions


Last updated: 31st of May 2021